Education
McCord received a Bachelor of Surgery degree in chemistry from Rhodes College (graduated 1966) and a Doctor of Philosophy in biochemistry from Duke University (graduated 1970), where he also conducted postdoctoral research.
McCord received a Bachelor of Surgery degree in chemistry from Rhodes College (graduated 1966) and a Doctor of Philosophy in biochemistry from Duke University (graduated 1970), where he also conducted postdoctoral research.
While serving as a graduate student, he and his supervisor Irwin Fridovich were the first to describe the enzymatic activity of superoxide dismutase. McCord joined the board of directors of the LifeVantage Corporation (makers of the dietary supplement Protandim) in 2006, serving as the company"s chief science officer from 2011 to 2012, and retired from the company in June 2013. McCord has held biochemistry faculty positions at Duke University Medical Center, University of South Alabama, and the University of Colorado Denver.
He holds an Honorary Doctorate from the University of Buenos Aires and has served as Honorary President of the International Society of Antioxidants in Nutrition and Health (ISANH) and as Chairman of the Third International Conference on Superoxide Dismutases at the Institut Pasteur.
McCord has served on the board of directors (Director of Science) of the LifeVantage Corporation since 2006 and is listed by the Securities and Exchange Commission as an insider shareholder. LifeVantage is a Utah-based multilevel marketing company that distributes an antioxidant dietary supplement known as Protandim.
McCord has co-authored 7 studies on the product and participates in distributor training. LifeVantage announced McCord’s retirement in June 2013.
Under the terms of the separation agreement, McCord was to receive a payment of $1.7 million from the company.
McCord served as Chief Scientific Officer for LifeVantage from June 2011 until September 2012, and then became a member of the company"s science advisory board.